Hemofarm is a member of STADA Group, one of the largest global generic pharmaceutical companies, which successfully operates also in the markets of Serbia and Western Balkans. Hemofarm produces high-quality pharmaceutical products within the leading pharmacotherapeutic groups, observing the key corporate values: care, quality, availability and trust.

We are looking for:

Expert Associate

in our Quality Assurance team to assure execution of all activities and processes in order to align with department and corporate goals and compliance with all regulatory requirements

Place of work: Vrsac

Profile:

• Faculty of Technology, Pharmacy, Chemistry or Biology
• Active knowledge of the English language – minimum B2 level
• Advanced level of knowledge of MS Office package
• Team-oriented, precise, analytical, responsible, independent
• Strong communication skills and assertivness
• Ability to work in a fast-paced, dynamic, environment
• Fast learner and easily adaptable to changes

Previous working experience in Pharma or Quality management area will be considered as advantage

Your duties and tasks:

• Active participation in Quality system processes, such as GMP documentation management, materials management, change control, deviation, CAPA, audits and others
• Maintaining and compiling GMP documentation – such as specifications, analytical procedures, risk assessments, different reports, questionnaires and other
• Evaluating GMP documentation in line with the applicable GMP guidelines and files approved by regulatory authorities;
• Data management in SAP, Sharepoints, Access DataBases, participation in implementation and improvement of Electronic Management Systems
• Drive improvements in Quality Assurance Documentation and processes
• Performing other tasks at the order of direct superior

Job offer:

• Work and responsible position
• Continuous learning environment
• Chance for a professional and personal development
• Good working conditions and positive working atmosphere

Deadline for submitting applications: 03.04.2019. 

For further information on Hemofarm, please visit the website hemofarm.com